We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Explainers relating to the Northern Ireland Troubles (Legacy and Reconciliation) Bill
How to contact MHRA for specific services or enquiries.
How we assess issues of potential regulatory concern
Find out how to appeal if Natural England serves you with a management notice for works on a site of special scientific interest (SSSI).
This series brings together all documents relating to ACMD inquiry reports
Guidance on regulations covering new power generating plants and wayleaves.
Common land and village greens: inquiries and hearings into applications for consent to carry out works or deregister land.
Use this form to request to be informed of future events relating to a patent application or patent.
Inquiring into all the circumstances surrounding allegations of unlawful killing by British Forces.
The CMA is investigating the anticipated acquisition by Roche Diagnostics Limited of certain entities held by LumiraDx Group Limited (in administration) and LumiraDx International Limited (in administration)
Find out when and how to appeal if Natural England refuses you consent to carry out an activity on a site of special scientific interest.
Actions that trial sponsors should consider to build resilience into clinical trial design
Guidance on obtaining consent for development of energy infrastructure: overhead lines.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
How investigators and sponsors should manage clinical trials during COVID-19
Information to help you answer your query before you contact us.
Upper Tribunal Tax and Chancery decision of Judge Rupert Jones and Judge Guy Brannan on 08 May 2024
Performance and other updates following the publication of our latest official monthly statistics.
This document sets out the aims of the public inquiry into the coronavirus (COVID-19) pandemic.
Advice on planning appeals and the award costs.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).